a lot of people are frustrated and scared. it s scary for the world, i guess. i anticipate there will be a lot of moving money to the bigger banks. neil: unbelievable. believe it. fox on top of it. a banking mess in the making and still messy. three banks have technically collapsed this month. actually in just the past week. so far fears of a contagion are not taking held. here s what we know. customers are nervous, make that very nervous. officials aren t helping matters in when they say don t worry. we ve got this. do they? we ve got you covered with kelly o grady outside silicon valley bank branch where customers have been lining up. peter doocy in san diego where the president is trying to tamp fears down. peter, what are traders watching? none other than carl icahn on where this crisis could be heading. welcome. i m neil cavuto. so much happening today in real time fast time market conditions. let s go right now to kelly in los angeles with the very latest from the
Japanese drug maker Takeda on Tuesday entered into a three-year memorandum of understanding (MoU) with the Biotechnology Industry Research Assistance Council (BIRAC) to foster healthcare innovation.
The team behind HealthXCapital, which invested in and helped health tech startups scale up, has joined Singapore-based Jungle Ventures. Seemant Jauhari, who led HealthXCapital since it was founded eight years ago, is now a partner at Jungle, where he will invest in healthcare startups in Southeast Asia and India. At Jungle, Jauhari will take a similar approach as he did at HealthXCapital, combining capital with strategic partners in the healthcare sector to help startups toward validation and commercialization.
The team behind HealthXCapital, which invested in and helped health tech startups scale up, has joined Singapore-based Jungle Ventures. Seemant Jauhari, who led HealthXCapital since it was founded eight years ago, is now a partner at Jungle, where he will invest in healthcare startups in Southeast Asia and India. At Jungle, Jauhari will take a similar approach as he did at HealthXCapital, combining capital with strategic partners in the healthcare sector to help startups toward validation and commercialization.